Do neuropsychological tests detect preclinical Alzheimer's disease: Individual-test versus cognitive-discrepancy score analyses

Neuropsychology

Volumn 16, Issue 2, 2002, Pages 132-139

  Jacobson, Mark W ^a,b   Delis, Dean C ^a,b   Bondi, Mark W ^a,b   Salmon, David P ^c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

EID: 0036211281     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.16.2.132     Document Type: Article

References (64)

1. Electrophysiologic comparisons between two groups of patients with Alzheimer's disease
2. Neuropsychological function in Alzheimer's disease: Pattern of impairment and rates of progression
3. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
4. Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults
5. Patterns of brain activation in people at risk for Alzheimer's disease
6. Neuropsychological patterns in right versus left frontotemporal dementia
7. Asymmetrical cerebral atrophy in Alzheimer's disease
8. Prediction of memory and language performance in normal elderly Canadians: Implications for the assessment of premorbid cognition in early Alzheimer's disease
9. Age related cognitive decline: A clinical entity? A longitudinal study of cerebral blood flow and memory performance
10. A power primer
11. The neuropsychology of preclinical Alzhemier's disease and mild cognitive impairment
12. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease
13. Spatial cognition in Alzheimer's disease: Subtypes of global-local impairment
14. Do subgroups of patients with Alzheimer's disease exhibit asymmetric deficits on memory tests?
15. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort
16. Cognitive process in preclinical phase of dementia
17. "Mini-Mental State": A practical method for grading the cognitive state of patients for the physician
18. Lesion parameters and performance on visuoperceptual and visuoconstructive tasks among brain-injured African American patients
19. Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
20. Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease
21. Age at onset and visuocognitive disturbances in Alzheimer disease
22. Choinesterase inhibitors stabilize Alzheimer disease
23. Alzheimer's disease with asymmetric atrophy of the cerebral hemispheres: Morphometric analysis of four cases
24. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type
25. Subgroups in dementia of the Alzheimer type identified using positron emission tomography
26. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease
27. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia
28. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type
29. Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment
30. Apolipoprotein E and Alzheimer's disease: A review of recent studies
31. Cortical dysfunction in non-demented Parkinson's disease patients: A combined (31)P-MRS and (18)FDG-PET study
32. Neuropsychological detection and characterization of preclinical Alzheimer's disease
33. Asymmetric cognitive profiles in the preclinical phase of Alzheimer's disease
34. Clinical and pathological evidence for a frontal variant of Alzheimer disease
35. Relating anatomy to function in Alzheimer's disease: Neuropsychological profiles predict regional neuropathology 5 years later
36. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia
37. Word-finding deficits persist after left anterotemporal lobectomy
38. The "preclinical phase" of probable Alzheimer's disease: A 13-year prospective study of the Framingham cohort
39. Neuropsychology of Alzheimer's disease: The case for subgroups
40. Towards a behavioral typology of Alzheimer's patients
41. Mechanisms of spatial impairment in Alzheimer's disease subgroups: Differential breakdown of directed attention to global-local stimuli
42. Hemispheric asymmetry in Alzheimer's disease is apparent in motor functioning
43. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease
44. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
45. Heterogeneity of cognitive profiles in normal aging: Implications for early manifestations of Alzheimer's disease
46. Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: A double cross-validation and application to a community-dwelling sample
47. Predicting rate of cognitive decline in probable Alzheimer's disease
48. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E
49. Visual confrontation naming and hippocampal function: A neural network study using quantitative (1)H magnetic resonance spectroscopy
50. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
51. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for Alzheimer disease
52. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control adults
53. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: Correlation to visual and verbal memory
54. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele
55. Neuropsychological asymmetry in Alzheimer's disease: Verbal versus visuoconstructional deficits across stages of dementia
56. Clinical trials in Alzheimer's disease
57. Cortical variability and asymmetry in normal aging and Alzheimer's disease
58. The WAIS as a lateralizing and localizing diagnostic instrument: A study of 656 patients with unilateral cerebral lesions